isocryptomerin and Hemolysis

isocryptomerin has been researched along with Hemolysis* in 1 studies

Other Studies

1 other study(ies) available for isocryptomerin and Hemolysis

ArticleYear
Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina.
    Biochemical and biophysical research communications, 2009, Feb-13, Volume: 379, Issue:3

    Isocryptomerin is a biflavonoid isolated from Selaginella tamariscina used in traditional medicine. In this study, we investigated novel antifungal properties of isocryptomerin. The results indicated that isocryptomerin exerted antifungal activity in an energy-independent manner without remarkable hemolytic effects. To understand mode of action(s) of isocryptomerin, we conducted experiments on Candida albicans, a noted human pathogenic fungal strain. Flow cytometric analysis with bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC(4)(3)], a translational membrane potential dye, regeneration test with fungal protoplasts, and fluorescence analysis with 1,6-diphenyl-1,3,5-hexatriene (DPH), a probe for membrane studies by depolarization, indicated that isocryptomerin could depolarize fungal plasma membrane. In conclusion, the results suggested that the antifungal activities of isocryptomerin might be due to its membrane-disruption mechanism(s).

    Topics: Antifungal Agents; Candida albicans; Cell Membrane; Diphenylhexatriene; Erythrocyte Membrane; Erythrocytes; Flavones; Fluorescent Dyes; Hemolysis; Humans; Membrane Potentials; Microbial Sensitivity Tests; Molecular Structure; Selaginellaceae

2009